Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;56(4):1069-1081.
doi: 10.1161/STROKEAHA.124.047070. Epub 2025 Jan 24.

The Kidney-Immune-Brain Axis: The Role of Inflammation in the Pathogenesis and Treatment of Stroke in Chronic Kidney Disease

Dearbhla M Kelly  1 , Eoin M Kelleher  2 , Peter M Rothwell  1
Affiliations
Review

The Kidney-Immune-Brain Axis: The Role of Inflammation in the Pathogenesis and Treatment of Stroke in Chronic Kidney Disease

Dearbhla M Kelly et al. Stroke. 2025 Apr.

Abstract

Cardiovascular diseases such as stroke are a major cause of morbidity and mortality for patients with chronic kidney disease (CKD). The underlying mechanisms connecting CKD and cardiovascular disease are yet to be fully elucidated, but inflammation is proposed to play an important role based on genetic association studies, studies of inflammatory biomarkers, and clinical trials of anti-inflammatory drug targets. There are multiple sources of both endogenous and exogenous inflammation in CKD, including increased production and decreased clearance of proinflammatory cytokines, oxidative stress, metabolic acidosis, chronic and recurrent infections, dialysis access, changes in adipose tissue metabolism, and disruptions in intestinal microbiota. This review focuses on the mechanisms of inflammation in CKD, dialysis and associated therapies, its proposed impact on stroke pathogenesis and prognosis, and the potential role of anti-inflammatory agents in the prevention and treatment of stroke in patients with CKD.

Keywords: cardiovascular diseases; inflammation; renal dialysis; renal insufficiency, chronic; stroke.

PubMed Disclaimer

Conflict of interest statement

Dr Rothwell has in the past provided consultancy services for Abbott Vascular, Bayer, Bristol-Myers Squibb, and Sanofi US Services. The other authors report no conflicts.

Figures

Figure 1.
Figure 1.
Sources of inflammation in chronic kidney disease (CKD). PAMPs indicate pathogen-associated molecular patterns.
Figure 2.
Figure 2.
Evidence supportive of the inflammatory hypothesis for stroke in chronic kidney disease (CKD). CRP indicates C-reactive protein; IL, interleukin; MPO, myeloproteinase; and TNF, tumor necrosis factor.
Figure 3.
Figure 3.
Proposed inflammatory targets and therapeutic strategies based on chronic kidney disease (CKD) stage and progression. CV indicates cardiovascular; GFR, glomerular filtration rate; GLP-1-RA, glucagon-like peptide-1 receptor agonist; IL, interleukin; nsMRA, nonsteroidal mineralocorticoid receptor antagonist; RAAS, renin-angiotensin-aldosterone system; ROS, reactive oxygen species; SGLT2i, sodium-glucose cotransporter 2 inhibitor; and T2DM, type 2 diabetes.
See this image and copyright information in PMC

References

    1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X - PubMed
    1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/s0140-6736(20)30045-3 - PMC - PubMed
    1. Kelly D, Rothwell PM. Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry. 2020;91:88–97. doi: 10.1136/jnnp-2019-320526 - PMC - PubMed
    1. Liu B, Lau KK, Li L, Lovelock C, Liu M, Kuker W, Rothwell PM. Age-specific associations of renal impairment with magnetic resonance imaging markers of cerebral small vessel disease in transient ischemic attack and stroke. Stroke. 2018;49:899–904. doi: 10.1161/STROKEAHA.117.019650 - PMC - PubMed
    1. Kelly DM, Pendlebury ST, Rothwell PM. Associations of chronic kidney disease with dementia before and after TIA and stroke: population-based cohort study. Neurology. 2022;98:e711–e720. doi: 10.1212/WNL.0000000000013205 - PMC - PubMed